Vascular Biosciences is a biotech company based in Durham, NC, specializing in the development of innovative solutions for hard-to-treat diseases. Their product portfolio includes CAR peptide technology, co-administered therapeutics, and molecular diagnostics, with applications ranging from pulmonary hypertension and sepsis to gene therapy and lung cancer.
With a focus on interventional medicine, Vascular Biosciences offers advanced technologies such as the endoarterial biopsy catheter, designed to facilitate precise diagnostic procedures. The company actively seeks collaborations with physicians, scientists, and researchers to drive innovation in the field and welcomes investment opportunities to further their mission of addressing unmet medical needs.
Generated from the website